ABVC BioPharma, Inc. Equity Securities, FV-NI, Gain (Loss)
ABVC BioPharma, Inc. (ABVC) reported Equity Securities, FV-NI, Gain (Loss) of -$79.06 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2024-08-14
- ABVC BioPharma, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-06-30 was -$79.06K.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month |
|---|---|---|
| 2024-06-30 | -$79.06K 10-Q · filed 2024-08-14 | -$79.06K 10-Q · filed 2024-08-14 |